In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...

Advanced Micro Devices Inc (NASDAQ: AMD) tumbled Wednesday after Citi downgraded the stock from Buy to Neutral, citing ...

A specially curated, four-course meal will be on the menu this Valentine’s Day at The Abbey Resort. On Friday, Feb. 14, the ...

By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

Taking place on Saturday 8 March, 2025 at Lindley Hall in London, British Watchmakers’ Day is a key event in the horological calendar, where visitors will experience a selection of new watches from ...

TrueFoundry, a startup offering enterprises a platform to deploy compound AI systems at scale, as raised $19 million in a ...

Google dropped a bunch of Gemini announcements, including broader availability of its reasoning model and the flagship Gemini ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

On Vertex's Q4 earnings call, investors will focus on management's comments about launch preparation for Alyftrek (vanza triple) and Journavx (suzetrigine).

Welbee, a multi-award-winning provider of survey solutions that support schools and trusts in gathering stakeholder feedback ...

The FDA has approved suzetrigine, a groundbreaking non-opioid painkiller that targets pain at its source, offering a safer, ...